CurrentPartnering Scorecards
Welcome to CurrentPartnering's Partnering Scorecards - resources to keep you updated on the state of business development in the biopharma sector.
Scorecard Index
Tracking deal activity - following chart is updated monthly to provide trend analysis of partnering and M&A announcements each month.
Partnering Top 25 - 2010
The leading partnering deals signed so far this year - partnering top 25 in 2010
Partnering Top 25 - 2009
The leading partnering deals signed so far this year - partnering top 25 in 2009
Partnering Top 25 - 2008
The leading partnering deals signed so far this year - partnering top 25 in 2008
Partnering Top 25 - 2007
The leading partnering deals signed in 2007 - partnering top 25 in 2007
Partnering since 2000
The leading partnering deals signed since the start of the new millenium - partnering since 2000
M&A Top 20 - 2010
The leading M&A deals signed so far this year - M&A top 20 in 2010
M&A Top 20 - 2009
The leading M&A deals signed so far this year - M&A top 20 in 2009
M&A Top 20 - 2008
The leading M&A deals signed so far this year - M&A top 20 in 2008
M&A Top 20 - 2007
The leading M&A deals signed in 2007 - M&A top 20 in 2007
M&A since 2000
The leading M&A deals signed since the start of the new millenium - M&A since 2000
Bigpharma Top 25 partnering 2009
The leading biopharmaceutical companies deal activity ranked by their annual revenues - Bigpharma top 50 partnering 2009
Biopharma R&D spend 2007
The leading biopharma companies by R&D spend - R&D spend top 20 in 2007
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Supplementary Protection Certificate (SPC) - granted to extend the period of protection under a patent in respect of a specified pharmaceutical (or plant protection) product that is protected by the patent